Michael O'Callaghan

Michael O'Callaghan

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

I am a clinical epidemiologist with expertise in:

  • Prostate Cancer
  • Urology
  • Clinical Registries
  • Evidence Based Medicine

  • Appointments
    Date Position Institution name
    2020 - ongoing Associate Professor Flinders University
    2016 - ongoing Affiliate Senior Lecturer University of Adelaide
    2015 - 2020 Affiliate Senior Lecturer Flinders University
    2014 - 2016 Visiting Research Fellow University of Adelaide
    2013 - ongoing Senior Researcher and Educator SA Health
    2013 - 2016 Honorary Affiliate Lecturer University of Adelaide, Robinson Institute
    2013 - 2013 Postdoctoral Research Fellow University of South Australia
    2012 - 2013 Postdoctoral Research Fellow University of Adelaide
    2011 - 2012 Endeavour Postdoctoral Research Fellow University of Auckland

  • Education
    Date Institution name Country Title
    2004 University of Adelaide, Department of Physiology Australia Honours Degree of Science
    2003 University of Adelaide, Department pf Physiology Australia Bachelor Degree of Science

  • Postgraduate Training
    Date Title Institution Country
    2008 - 2011 PhD candidate with the Discipline of Obstetrics and Gynaecology University of Adelaide, Faculty of Health and Medical Sciences Australia

  • Certifications
    Date Title Institution name Country
    2019 Statistical Practice in Epidemiology using R University of Tartu Estonia
    2018 Postgraduate Research Supervision Program Flinders University Australia
    2018 Good Clinical Practice NIDA Clinical Trials Network -
    2013 Epidemiological Methods International Epidemiological Association China
    2012 Analysis of Linked Data Statistical Society of Australia -
    2009 Future Research Leaders Program Go8 Universities of Australia -
    2008 Cochrane Review methods Australasian Cochrane Centre -

  • Research Interests
    Epidemiology Public Health and Health Services Surgery Urology & Nephrology

  • Journals
    Year Citation
    2024 Tiruye, T., O'Callaghan, M., FitzGerald, L. M., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2024). Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection. Clinical Genitourinary Cancer, 22(2), 599-609.e2.
    DOI
    2024 Tempo, J. A., Sii, S., Ischia, J., Bolton, D. M., D'Onise, K., Meng, R., . . . O'Callaghan, M. (2024). Lessons from a population-based bladder cancer registry: exploring why survival is not improving. BJU International, 10 pages.
    DOI
    2024 Tiruye, T., O'Callaghan, M., Ettridge, K., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2024). Clinical and functional outcomes for risk-appropriate treatments for prostate cancer. BJUI Compass, 5(1), 109-120.
    DOI Scopus1 WoS1
    2024 O'Callaghan, M., Bulamu, N., Gormly, K., & Jay, A. (2024). Re: Prevalence of MRI Lesions in Men Responding to a GP-led Invitation for a Prostate Health Check: A Prospective Cohort Study. European Urology, 85(4), 395.
    DOI
    2024 Tiruye, T., Roder, D., FitzGerald, L. M., O'Callaghan, M., Moretti, K., & Beckmann, K. (2024). Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer. Cancer Epidemiology, 88, 7 pages.
    DOI Scopus1
    2024 Borg, M. A., O’Callaghan, M. E., Moretti, K. L., & Vincent, A. D. (2024). External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate cancer subjects. BMC Urology, 24(1), 8 pages.
    DOI
    2024 Rabinowitz, J., Kinnear, N., O’Callaghan, M., Hennessey, D., Shafi, F., Fuller, A., . . . Vasdev, N. (2024). Systematic review of the ophthalmic complications of robotic-assisted laparoscopic prostatectomy. Journal of Robotic Surgery, 18(1), 8 pages.
    DOI
    2023 Tempo, J., Bolton, D., & O'Callaghan, M. (2023). Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and <i>carcinoma in situ</i> transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507). BMC UROLOGY, 23(1), 4 pages.
    DOI
    2023 Alghazo, O., & O’Callaghan, M. (2023). PSMA-PET to detect prostate cancer recurrence after radiotherapy. Nature Reviews Urology, 20(1), 5-6.
    DOI Scopus1 Europe PMC1
    2023 Tiruye, T., O'Callaghan, M., Ettridge, K., Jay, A., Santoro, K., Moretti, K., & Beckmann, K. (2023). Factors impacting on sexual function among men on active surveillance for prostate cancer. Prostate, 83(7), 678-687.
    DOI Scopus1
    2023 John, A., Lim, A., Catterwell, R., Selth, L., & O’Callaghan, M. (2023). Length of positive surgical margins after radical prostatectomy: Does size matter? – A systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 26(4), 673-680.
    DOI Scopus1 Europe PMC1
    2023 Bulamu, N. B., Mpundu-Kaambwa, C., O'Callaghan, M., & Kaambwa, B. (2023). Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer.. BMC cancer, 23(1), 13 pages.
    DOI
    2023 Tiruye, T., Ettridge, K., O'Callaghan, M., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2023). Reporting Real-World Data on Prostate Cancer Treatment Outcomes to Consumers: The Prostate Cancer Report Card. European Journal of Cancer Care, 2023, 12 pages.
    DOI
    2023 Tiruye, T., Roder, D., FitzGerald, L. M., O'Callaghan, M., Moretti, K., & Beckmann, K. (2023). Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer. Cancer Epidemiology, 87, 6 pages.
    DOI Scopus2
    2023 Shugg, N., & O'Callaghan, M. E. (2023). Seminal papers in urology: anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.. BMC urology, 23(1), 1-4.
    DOI
    2023 O' Callaghan, M. E., Roberts, M., Grummet, J., Mark, S., Gilbourd, D., Frydenberg, M., . . . Papa, N. (2023). Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand. Urologic Oncology: Seminars and Original Investigations, 41(7), 324.e13-324.e20.
    DOI
    2023 O'Callaghan, M. (2023). Re: Addition of Nintedanib or Placebo to Neoadjuvant Gemcitabine and Cisplatin in Locally Advanced Muscle-invasive Bladder Cancer (NEOBLADE): A Double-blind, Randomised, Phase 2 Trial. European Urology, 84(4), 440-441.
    DOI
    2023 Beckmann, K. R., O'Callaghan, M. E., Vincent, A. D., Moretti, K. L., & Brook, N. R. (2023). Clinical outcomes for men with positive surgical margins after radical prostatectomy—results from the South Australian Prostate Cancer Clinical Outcomes Collaborative community-based registry. Asian Journal of Urology, 10(4), 502-511.
    DOI Scopus1 WoS1
    2023 Mac Curtain, B. M., Sugrue, D. D., Qian, W., O'Callaghan, M., & Davis, N. F. (2023). Membranous urethral length and urinary incontinence following robot-assisted radical prostatectomy: a systematic review and meta-analysis. BJU International, 10 pages.
    DOI
    2023 O'Callaghan, M. E., Roberts, M. J., Moretti, K. L., Frydenberg, M., Gilbourd, D., Mark, S., . . . Papa, N. (2023). Variation in patient reported outcomes following radical prostatectomy: A bi-national registry-based study. Urologic Oncology: Seminars and Original Investigations, 41(2), 105.e9-105.e18.
    DOI Scopus2 Europe PMC1
    2023 Tempo, J., Yiu, T. W., Ischia, J., Bolton, D., & O'Callaghan, M. (2023). Global changes in bladder cancer mortality in the elderly. Cancer Epidemiology, 82, 10 pages.
    DOI Scopus2
    2023 Wei, G., Harley, F., O’Callaghan, M., Adshead, J., Hennessey, D., & Kinnear, N. (2023). Systematic review of urological injury during caesarean section and hysterectomy. International Urogynecology Journal, 34(2), 371-389.
    DOI Scopus1
    2023 Harley, F., Wei, G., O'Callaghan, M., Wong, L. M., Hennessey, D., & Kinnear, N. (2023). Xanthogranulomatous pyelonephritis: a systematic review of treatment and mortality in more than 1000 cases. BJU International, 131(4), 395-407.
    DOI Scopus9 WoS6 Europe PMC6
    2023 David, R., Buckby, A., Kahokehr, A. A., Lee, J., Watson, D. I., Leung, J., & O’Callaghan, M. E. (2023). Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 26(1), 8-15.
    DOI Scopus5 WoS2 Europe PMC2
    2022 Hiwase, M. D., Jay, A., Bulamu, N., Teh, J., Paterson, F., Kichenadasse, G., . . . Walsh, S. (2022). Evaluation of selective bone scan staging in prostate cancer – external validation of current strategies and decision-curve analysis. Prostate Cancer and Prostatic Diseases, 25(2), 336-343.
    DOI
    2022 McIntosh, M., Opozda, M. J., O’Callaghan, M., Vincent, A. D., Galvão, D. A., & Short, C. E. (2022). Why do men with prostate cancer discontinue active surveillance for definitive treatment? A mixed methods investigation. Psycho-Oncology, 31(8), 1420-1430.
    DOI Scopus4 WoS2 Europe PMC4
    2022 McIntosh, M., Opozda, M. J., O’Callaghan, M., Vincent, A. D., Galvão, D. A., & Short, C. E. (2022). Impact of different unconditional monetary incentives on survey response rates in men with prostate cancer: a 2-arm randomised trial. BMC Medical Research Methodology, 22(1), 8 pages.
    DOI
    2022 David, R. V., Kahokehr, A. A., Lee, J., Watson, D. I., Leung, J., & O’Callaghan, M. E. (2022). Incidence of genitourinary complications following radiation therapy for localised prostate cancer. World Journal of Urology, 40(10), 2411-2422.
    DOI Scopus5 WoS3 Europe PMC3
    2022 David, R., Hiwase, M., Kahokehr, A. A., Lee, J., Watson, D. I., Leung, J., & O‘Callaghan, M. E. (2022). Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer. World Journal of Urology, 40(12), 2911-2918.
    DOI
    2022 Tiruye, T., O’Callaghan, M., Moretti, K., Jay, A., Higgs, B., Santoro, K., . . . Beckmann, K. (2022). Patient-reported functional outcome measures and treatment choice for prostate cancer. BMC Urology, 22(1), 11 pages.
    DOI Scopus4 WoS1 Europe PMC3
    2022 Radbone, C., Beckmann, K., Roder, D., O'Callaghan, M., Moretti, K., Fitzgerald, L., & Buckley, L. (2022). Multi-jurisdictional Prostate Cancer Registry Linkage. International Journal of Population Data Science, 7(3).
    DOI
    2022 Chan, K. M., Gleadle, J. M., O’Callaghan, M., Vasilev, K., & MacGregor, M. (2022). Prostate cancer detection: a systematic review of urinary biosensors. Prostate Cancer and Prostatic Diseases, 25(1), 39-46.
    DOI Scopus15 WoS12 Europe PMC6
    2022 Li, J. Y., Bodda, S., Jay, A., Kichenadasse, G., Chong, M., Gleadle, J. M., & O’Callaghan, M. (2022). Protocol for the Flinders Kidney Health Registry: patient outcomes of kidney cancers and nephrectomies. BMC Urology, 22(1), 8 pages.
    DOI
    2021 Soo, A., O’Callaghan, M. E., Kopsaftis, T., Vatandoust, S., Moretti, K., & Kichenadasse, G. (2021). PSA response to antiandrogen withdrawal: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 24(3), 826-836.
    DOI Scopus2 WoS3 Europe PMC2
    2021 O’Callaghan, M., Papa, N., Pase, M., Frydenberg, M., Mark, S., Moretti, K., . . . Millar, J. (2021). Patterns of care for prostate cancer treatment and improving outcomes – are national registries the answer?. BJU International, 128(S1), 6-8.
    DOI Scopus11 WoS10 Europe PMC5
    2021 Jay, A. P. M., Aldiwani, M., O'Callaghan, M. E., Pearce, A. K., Huddart, R. A., Mayer, E., . . . Nicol, D. L. (2021). Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour. European Urology Open Science, 29, 82-88.
    DOI Scopus1 WoS1 Europe PMC1
    2021 Kinnear, N., Jolly, S., Herath, M., Han, J., Tran, M., O'Callaghan, M., . . . Moore, J. (2021). The acute surgical unit: An updated systematic review and meta-analysis. International Journal of Surgery, 94(October), 1-13.
    DOI Scopus5 WoS4 Europe PMC2
    2021 Pryor, D. I., Martin, J. M., Millar, J. L., Day, H., Ong, W. L., Skala, M., . . . Papa, N. (2021). Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and NewZealand. JAMA Network Open, 4(11), E2129647.
    DOI Scopus13 WoS8 Europe PMC9
    2020 Lin, D., O'Callaghan, M. E., David, R., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (2020). Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?.
    DOI
    2020 Tempo, J., Logan, C., O'Callaghan, M., Kahokehr, A., Kichenadasse, G., D'Onise, K., & Foreman, D. (2020). Bladder, penile, renal pelvis and testis cancers: A population based analysis of incidence and survival 1977-2013. Cancer Epidemiology, 65, 8 pages.
    DOI Scopus6 WoS4 Europe PMC4
    2020 John, A., O'Callaghan, M., Catterwell, R., & Selth, L. (2020). Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review. BMJ Open, 10(3), 4 pages.
    DOI Scopus4 WoS3 Europe PMC2
    2020 Kinnear, N., Herath, M., Jolly, S., Han, J., Tran, M., Parker, D., . . . Moore, J. (2020). Patient Satisfaction in Emergency General Surgery: A Prospective Cross-Sectional Study. World J Surg, 44(9), 2950-2958.
    DOI Scopus4 WoS3 Europe PMC1
    2020 Ang, M., Borg, M., & O'Callaghan, M. E. (2020). Survival outcomes in men with a positive family history of prostate cancer: A registry based study. BMC Cancer, 20(1), 8 pages.
    DOI Scopus11 WoS8 Europe PMC7
    2020 O'Callaghan, M., Jay, A., Kichenadasse, G., & Moretti, K. (2020). Androgen Deprivation Therapy in Unlikely to be Effective for Treatment of COVID-19.. Ann Oncol, 31(12), 1780-1782.
    DOI Scopus8 WoS6 Europe PMC7
    2020 Kinnear, N., Barnett, D., O'Callaghan, M., Horsell, K., Gani, J., & Hennessey, D. (2020). The impact of catheter-based bladder drainage method on urinary tract infection risk in spinal cord injury and neurogenic bladder: A systematic review.. Neurology and Urodynamics, 39(2), 854-862.
    DOI Scopus42 WoS30 Europe PMC21
    2020 Jones, B. C., Youlden, D. R., Cundy, T. P., O'Callaghan, M. E., Karpelowsky, J., Aitken, J. F., & McBride, C. A. (2020). Renal tumours in Australian children: 30 years of incidence, outcome and second primary malignancy data from the Australian Childhood Cancer Registry. Journal of Paediatrics and Child Health, 56(6), 908-916.
    DOI Scopus2 WoS2 Europe PMC1
    2020 Lin, D., O'Callaghan, M., David, R., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (2020). Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?. BMC Urology, 20(1), 7 pages.
    DOI Scopus16 WoS17 Europe PMC6
    2020 Morias, S., Buckley, E., Beckmann, K., O'Callaghan, M., Borg, M., & Short, M. (2020). Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005–2015. Radiotherapy and Oncology, 145, 138-145.
    DOI Scopus1 WoS1
    2020 Lu, T. C., Collins, L., Cohen, P., Jay, A., Campbell, J. M., & O’Callaghan, M. (2020). Prognostic Differences in ISUP Grade Group 4: a Systematic Review and Meta-Analysis. Pathology and Oncology Research, 26(3), 1367-1375.
    DOI Scopus4 WoS3 Europe PMC3
    2019 Beckmann, K., O'Callaghan, M., Vincent, A., Cohen, P., Borg, M., Roder, D., . . . Moretti, K. (2019). Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings.. Asian journal of urology, 6(4), 321-329.
    DOI Scopus7 WoS6 Europe PMC7
    2019 Kinnear, N., O'Callaghan, M., Hennessey, D., Liddell, H., Newell, B., Bolt, J., & Lawrentschuk, N. (2019). Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies. BJU International, 123(2), 210-219.
    DOI Scopus12 WoS14 Europe PMC5
    2019 Lin, D., O'Callaghan, M. E., David, R., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (2019). Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?.
    DOI
    2019 Forgione, M., Sara, S., Vincent, A. D., Borg, M., Moretti, K., & O'Callaghan, M. E. (2019). Satisfaction with care in men with prostate cancer. European Journal of Cancer Care, 28(4), e13028-1-e13028-8.
    DOI Scopus4 WoS4 Europe PMC1
    2019 Ellsworth, J. L., Gingras, J., Smith, L. J., Rubin, H., Seabrook, T. A., Patel, K., . . . Seymour, A. (2019). Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primates. PLOS ONE, 14(11), 33 pages.
    DOI WoS14
    2019 McMahon, J., Ryan, F., Cannon, M., O'Brien, G., O'Callaghan, M., Flanagan, R., . . . McGorry, P. (2019). Where next for youth mental health services in Ireland?. IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE, 36(3), 163-167.
    DOI WoS8
    2018 Ellsworth, J. L., O'Callaghan, M., Rubin, H., & Seymour, A. (2018). Low Seroprevalence of Neutralizing Antibodies Targeting Two Clade F AAV in Humans. HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 29(1), 60-67.
    DOI WoS11
    2018 Ellsworth, J. L., O'Callaghan, M., Rubin, H., & Seymour, A. (2018). Low Seroprevalence of Neutralizing Antibodies Targeting Two Clade F AAV in Humans (vol 29, pg 60, 2017). HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 29(2), 113.
    DOI
    2018 Aref, A., Vincent, A. D., O'Callaghan, M., Martin, S., Sutherland, P., Hoy, A., . . . Wittert, G. (2018). The inverse relationship between prostate specific antigen (PSA) and obesity. Endocrine-Related Cancer, 25(11), 933-941.
    DOI Scopus16 WoS13 Europe PMC12
    2018 Neumann, P. B., & O'Callaghan, M. (2018). The role of preoperative puborectal muscle function assessed by transperineal ultrasound in urinary continence outcomes at 3, 6, and 12 months after robotic-assisted radical prostatectomy. International Neurourology Journal, 22(2), 114-122.
    DOI Scopus12 WoS12 Europe PMC3
    2018 Burdett, N., Vincent, A., O'Callaghan, M., & Kichenadasse, G. (2018). Competing risks in older patients with cancer: A systematic review of geriatric oncology trials. Journal of the National Cancer Institute, 110(8), 825-830.
    DOI Scopus30 WoS25 Europe PMC19
    2018 Lu, T. C., Moretti, K., Beckmann, K., Cohen, P., & O Callaghan, M. (2018). ISUP Group 4 – a Homogenous Group of Prostate Cancers?. Pathology and Oncology Research, 24(4), 921-925.
    DOI Scopus8 WoS7 Europe PMC4
    2018 Moretti, K. L., Shi, Z., Kopsaftis, T., & O’Callaghan, M. E. (2018). Delays in radical prostatectomy for prostate cancer and survival outcomes. World Journal of Urology, 36(8), 1337-1338.
    DOI
    2018 Vatandoust, S., Kichenadasse, G., O'Callaghan, M., Vincent, A., Kopsaftis, T., Walsh, S., . . . Moretti, K. (2018). Localized prostate cancer in elderly men aged 80-89, findings from a population-based registry.. BJU international, 121(S3), 48-54.
    DOI Scopus14 WoS12 Europe PMC4
    2018 Moretti, K., Vatandoust, S., Kichenadasse, G., O’callaghan, M. E., Vincent, A. D., Kopsaftis, T., . . . Karapetis, C. (2018). Prostate cancer mortality is high in the elderly and can be reduced by selective individualized curative treatment. World Journal of Urology, 36(11), 1799-1800.
    DOI Scopus1 WoS1 Europe PMC1
    2018 Beckmann, K., O'Callaghan, M., Vincent, A., Roder, D., Millar, J., Evans, S., . . . Moretti, K. (2018). Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy. ANZ Journal of Surgery, 88(3), E183-E188.
    DOI Scopus2 WoS2
    2018 Hoffmann, R., Logan, C., O Callaghan, M., Gormly, K., Chan, K., & Foreman, D. (2018). Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?. International Urology and Nephrology, 50(1), 13-19.
    DOI Scopus11 WoS9 Europe PMC8
    2017 Beckmann, K., O'Callaghan, M., Ruseckaite, R., Kinnear, N., Miller, C., Evans, S., . . . Moretti, K. (2017). Prostate cancer outcomes for men who present with symptoms at diagnosis. BJU International, 119(6), 862-871.
    DOI Scopus6 WoS6 Europe PMC3
    2017 O'Callaghan, M. E., Shi, Z., Kopsaftis, T., & Moretti, K. (2017). Prostate cancer outcomes and delays in care. International Urology and Nephrology, 49(3), 449-455.
    DOI Scopus9 WoS9 Europe PMC6
    2017 Raymond, E., O'Callaghan, M., Campbell, J., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review. Radiation Oncology, 12(1), 56-1-56-20.
    DOI Scopus13 WoS12 Europe PMC4
    2017 Campbell, J., O'Callaghan, M., Raymond, E., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity. Clinical Genitourinary Cancer, 15(6), 629-634.
    DOI Scopus6 WoS4 Europe PMC4
    2017 O'Callaghan, M., Raymond, E., Campbell, J., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: A systematic review of prognostic accuracy and validity. Prostate Cancer and Prostatic Diseases, 20(4), 378-388.
    DOI Scopus19 WoS15 Europe PMC10
    2017 Campbell, J., Raymond, E., O'Callaghan, M., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity. Clinical Genitourinary Cancer, 15(5), e827-e834.
    DOI Scopus15 WoS12 Europe PMC10
    2017 O'Callaghan, M. E., Raymond, E., Campbell, J. M., Vincent, A. D., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Patient-reported outcomes after radiation therapy in men with prostate cancer: a systematic review of prognostic tool accuracy and validity. International Journal of Radiation Oncology Biology Physics, 98(2), 318-337.
    DOI Scopus10 WoS9 Europe PMC6
    2017 Beckmann, K., Vincent, A., O'Callaghan, M., Cohen, P., Chang, S., Borg, M., . . . Moretti, K. (2017). Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings. BMC cancer, 17(1), 537.
    DOI Scopus3 WoS3 Europe PMC1
    2017 Mack, D. L., Poulard, K., Goddard, M. A., Latoumerie, V., Snyder, J. M., Grange, R. W., . . . Childers, M. K. (2017). Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs. MOLECULAR THERAPY, 25(4), 839-854.
    DOI WoS70
    2016 Ruseckaite, R., Beckmann, K., O'Callaghan, M., Roder, D., Moretti, K., Millar, J., & Evans, S. (2016). A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease. BMC Cancer, 16(1), 11 pages.
    DOI Scopus21 WoS20 Europe PMC10
    2016 Ruseckaite, R., Beckmann, K., O'Callaghan, M., Roder, D., Moretti, K., Zalcberg, J., . . . Evans, S. (2016). Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset. BMC Research Notes, 9(1), 37.
    DOI Scopus4 Europe PMC3
    2016 Ang, M., Rajcic, B., Foreman, D., Moretti, K., & O'Callaghan, M. (2016). Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL. BJU international, 117(Suppl. 4), 68-75.
    DOI Scopus18 WoS19 Europe PMC14
    2016 Kinnear, N., Kichenadasse, G., Plagakis, S., O'Callaghan, M., Kopsaftis, T., Walsh, S., & Foreman, D. (2016). Prostate cancer in men aged less than 50 years at diagnosis. World Journal of Urology, 34(11), 1533-1539.
    DOI Scopus19 WoS16 Europe PMC14
    2015 Roberts, R., Miller, M., O'Callaghan, M., & Koczwara, B. (2015). Bone health management of Australian breast cancer survivors receiving hormonal therapy. Internal Medicine Journal, 45(11), 1182-1185.
    DOI Scopus2 WoS1 Europe PMC1
    2015 McMichael, G., Bainbridge, M., Haan, E., Corbett, M., Gardner, A., Thompson, S., . . . MacLennan, A. (2015). Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Molecular Psychiatry, 20(2), 176-182.
    DOI Scopus157 WoS123 Europe PMC100
    2015 O'Callaghan, M. (2015). Cancer risk: accuracy of literature. Science, 347(6223), 729.
    DOI Scopus23 WoS20 Europe PMC15
    2015 O'Callaghan, M., Kichenadasse, G., Vatandoust, S., & Moretti, K. (2015). Informed decision making about prostate cancer screening. Annals of Internal Medicine, 162(6), 457.
    DOI Scopus1 WoS1
    2015 Plagakis, S., Edwards, S., O'Callaghan, M., & Foreman, D. (2015). Predicting bladder cancer death amongst Australian Veterans. Journal of Military and Veterans' Health, 23(1), 4-9.
    2013 O'Callaghan, M., & MacLennan, A. (2013). Cesarean delivery and cerebral palsy: A systematic review and meta-analysis. Obstetrics and Gynecology, 122(6), 1169-1175.
    DOI Scopus36 WoS31 Europe PMC22
    2013 O'Callaghan, M., MacLennan, A., McMichael, G., Haan, E., & Dekker, G. (2013). Single-nucleotide polymorphism associations with preterm delivery: a case-control replication study and meta-analysis. Pediatric Research, 74(4), 433-438.
    DOI Scopus8 WoS5 Europe PMC5
    2013 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2013). Genetic and clinical contributions to cerebral palsy: A multi-variable analysis. Journal of Paediatrics and Child Health, 49(7), 575-581.
    DOI Scopus18 WoS9 Europe PMC7
    2013 O'Callaghan, M., & MacLennan, A. (2013). Brain damage and maternal medication. American Journal of Obstetrics and Gynecology, 208(2), 160-161.
    DOI
    2013 O'Callaghan, M. (2013). Apolipoprotein E and the genetics of cerebral palsy - where to next?. Developmental Medicine and Child Neurology, 55(4), 302-303.
    DOI
    2013 Lawlor, M. W., Armstrong, D., Viola, M. G., Widrick, J. J., Meng, H., Grange, R. W., . . . Beggs, A. H. (2013). Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. HUMAN MOLECULAR GENETICS, 22(8), 1525-1538.
    DOI WoS55
    2012 Stefano, J. E., Bird, J., Kyazike, J., Cheng, A. W. -M., Boudanova, E., Dwyer, M., . . . Pan, C. Q. (2012). High-Affinity VEGF Antagonists by Oligomerization of a Minimal Sequence VEGF-Binding Domain. BIOCONJUGATE CHEMISTRY, 23(12), 2354-2364.
    DOI WoS8
    2012 Hogg, S. R., Muthu, S., O'Callaghan, M., Lahitte, J. -F., & Bruening, M. L. (2012). Wet Air Oxidation of Formic Acid Using Nanoparticle-Modified Polysulfone Hollow Fibers as Gas-Liquid Contactors. ACS APPLIED MATERIALS & INTERFACES, 4(3), 1440-1448.
    DOI WoS5
    2012 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2012). Fetal and maternal candidate single nucleotide polymorphism associations with Cerebral Palsy: a case-control study. Pediatrics, 129(2), E414-E423.
    DOI Scopus33 WoS23 Europe PMC19
    2011 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). Epidemiologic associations with cerebral palsy. Obstetrics and Gynecology, 118(3), 576-582.
    DOI Scopus96 WoS85 Europe PMC56
    2011 McMichael, G., Highet, A., Gibson, C., Goldwater, P., O'Callaghan, M., Alvino, E., & MacLennan, A. (2011). Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research. Journal of Biomolecular Techniques, 22(1), 5-9.
    Scopus6 Europe PMC4
    2011 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). The Australian cerebral palsy research study - Protocol for a national collaborative study investigating genomic and clinical associations with cerebral palsy. Journal of Paediatrics and Child Health, 47(3), 99-110.
    DOI Scopus12 WoS9 Europe PMC7
    2010 Kremmidiotis, G., Leske, A., Lavranos, T., Beaumont, D., Gasic, J., Hall, A., . . . Flynn, B. (2010). BNC105: a novel tubulin polymerization inhibitor that selectively disrupts tumor vasculature and displays single-agent antitumor efficacy. Molecular Cancer Therapeutics, 9(6), 1562-1573.
    DOI Scopus76 WoS67 Europe PMC42
    2009 McMichael, G., Gibson, C., O'Callaghan, M., Goldwater, P., Dekker, G., Haan, E., & MacLennan, A. (2009). DNA from Buccal Swabs Suitable for High-Throughput SNP Multiplex Analysis. Journal of Biomolecular Techniques, 20(5), 232-235.
    Scopus29 Europe PMC20
    2009 O'Callaghan, M., MacLennan, A., Haan, E., & Dekker, G. (2009). The genomic basis of cerebral palsy: A HuGE systematic literature review. Human Genetics, 126(1), 149-172.
    DOI Scopus49 WoS39 Europe PMC34
    2008 Scott, J., Welham, J., Martin, G., Bor, W., Najman, J., O'Callaghan, M., . . . McGrath, J. (2008). Demographic correlates of psychotic-like experiences in young Australian adults. ACTA PSYCHIATRICA SCANDINAVICA, 118(3), 230-237.
    DOI WoS82
    2004 Najman, J. M., Aird, R., Bor, W., O'Callaghan, M., Williams, G. M., & Shuttlewood, G. J. (2004). The generational transmission of socioeconomic inequalities in child cognitive development and emotional health. SOCIAL SCIENCE & MEDICINE, 58(6), 1147-1158.
    DOI WoS119
    2003 Bor, W., Brennan, P. A., Williams, G. M., Najman, J. M., & O'Callaghan, M. (2003). A mother's attitude towards her infant and child behaviour five years later. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 37(6), 748-755.
    DOI WoS16
    - Visscher, J., Hiwase, M., Bonevski, B., & O'Callaghan, M. (n.d.). The association of smoking with urinary and sexual function recovery following radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis. PROSTATE CANCER AND PROSTATIC DISEASES, 8 pages.
    DOI

  • Conference Papers
    Year Citation
    2023 Subashi, E., Yousef-Zadeh, H., Cottin, S., Kemp, D., Lamontagne, A., O'Callaghan, M., . . . Cartier, N. (2023). Restoration of Brain Cholesterol Metabolism as Gene Therapy Strategy in Huntington's Disease: Unilateral Injections Are Insufficient to Elicit a Treatment Effect in HD Mice. In MOLECULAR THERAPY Vol. 31 (pp. 598-599). CELL PRESS.
    2022 Henry, T., Chung, E., Traverse, J., Reynolds, K., Alvisi, M., Ervin, L., . . . Hajjar, R. (2022). A First-in-Human Phase 1 Clinical Gene Therapy Trial for the Treatment of Heart Failure Using a Novel Re-Engineered Adeno-Associated Vector. In MOLECULAR THERAPY Vol. 30 (pp. 14-15). CELL PRESS.
    2022 Tempo, J., O'Callaghan, M., & Bolton, D. (2022). A global review of bladder cancer mortality in the elderly. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 122). WILEY.
    2022 Tempo, J., O'Callaghan, M., & Bolton, D. (2022). Exploring South Australia's decreasing bladder cancer survival. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 122-123). WILEY.
    2022 David, R., & O'Callaghan, M. (2022). Ten-year cumulative incidence and burden associated with treatment-related toxicity in men with localised prostate cancer. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 105). WILEY.
    2022 David, R., & O'Callaghan, M. (2022). Comparison of patient-reported outcomes measures in patients with localised prostate cancer following external beam radiotherapy or radical prostatectomy. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 105-106). WILEY.
    2022 John, A., Lim, A., Catterwell, R., Seth, L., & O'Callaghan, M. (2022). Does size matter? Extension of positive surgical margins after radical prostatectomy - a systematic review and meta-analysis. In EUROPEAN UROLOGY Vol. 81 (pp. S258). ELSEVIER.
    2022 O'Callaghan, M., Roberts, M., Grummet, J., Mark, S., Gilbourd, D., Frydenberg, M., . . . Papa, N. (2022). Population-wide trends and variation in prostate cancer diagnosis via transperineal biopsy. In BJU INTERNATIONAL Vol. 129 (pp. 157). Gold Coast, AUSTRALIA: WILEY.
    2022 Tiruye, T., O'Callaghan, M., Moretti, K., Jay, A., Higgs, B., Santoro, K., . . . Beckmann, K. (2022). Patient-reported functional outcome measures at baseline and 12 months post-treatment and their association with treatment choice for prostate cancer. In BJU INTERNATIONAL Vol. 129 (pp. 19). Gold Coast, AUSTRALIA: WILEY.
    2022 Wei, G., Harley, F., O'Callaghan, M., Adshead, J., Hennessey, D., & Kinnear, N. (2022). A systematic review of bladder and ureteric injury during caesarean section and hysterectomy; incidence, risk factors and prevention. In BJU INTERNATIONAL Vol. 129 (pp. 13-14). Gold Coast, AUSTRALIA: WILEY.
    2022 Harley, F., Wei, G., O'Callaghan, M., Wong, L. -M., Hennessey, D., & Kinnear, N. (2022). Demographics, treatment, and mortality of 1,139 cases of xanthogranulomatous pyelonephritis; a systematic review. In BJU INTERNATIONAL Vol. 129 (pp. 55-56). Gold Coast, AUSTRALIA: WILEY.
    2022 John, A., Catterwell, R., Lim, A., Selth, L., & O'Callaghan, M. (2022). Extension of positive surgical margins after radical prostatectomy: Does size matter? - A systematic review and meta-analysis. In BJU INTERNATIONAL Vol. 129 (pp. 139). Gold Coast, AUSTRALIA: WILEY.
    2022 John, A., Milton, T., Gupta, A., Stretton, B., Hewitt, J., Catteerwell, R., . . . O'Callaghan, M. (2022). Location of positive surgical margins after radical prostatectomy- A systematic review and network meta-analysis. In BJU INTERNATIONAL Vol. 129 (pp. 26-27). Gold Coast, AUSTRALIA: WILEY.
    2022 John, A., Milton, T., Gupta, A., Nguyen, M., Stretton, B., Hewitt, J., . . . O'Callaghan, M. (2022). Does location of positive surgical margins after radical prostatectomy matter?-A systematic review and network meta-analysis. In INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 (pp. 13-14). WILEY.
    2022 Doolette, I., Jay, A., Pathi, R., Ayres, O., O'Callaghan, M., Bodda, S., . . . Williams, G. (2022). Survival and peri-operative safety outcomes of thermal ablation versus partial nephrectomy for cT1 renal cell cancer at an Australian tertiary institution. In BJU INTERNATIONAL Vol. 129 (pp. 54-55). Gold Coast, AUSTRALIA: WILEY.
    2022 David, R., Buckby, A., Kahokehr, A., Lee, J., Watson, D., Leung, J., & Ocallaghan, M. (2022). Predicting genitourinary toxicity after radiotherapy treatment for localised prostate cancer. In BJU INTERNATIONAL Vol. 129 (pp. 24-25). Gold Coast, AUSTRALIA: WILEY.
    2020 Kinnear, N., Barnett, D., O'Callaghan, M., Horsell, K., Gani, J., & Hennessey, D. (2020). The impact of catheter-based bladder drainage method on urinary tract infection risk in neurogenic bladder; a systematic review. In BJU INTERNATIONAL Vol. 125 (pp. 10). Sydney, AUSTRALIA: WILEY.
    2019 O'Callaghan, M. (2019). Prostate cancer screening: Confusion, controversy and enlightenment. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 15 (pp. 97-98). WILEY.
    2019 Beckman, K., O'Callaghan, M., Moretti, K., Vincent, A., & Brook, N. (2019). Clinical and pathological factors associated with positive surgical margins in patients undergoing radical prostatectomy from the SA-PCCOC. In BJU INTERNATIONAL Vol. 123 (pp. 69-70). Brisbane, AUSTRALIA: WILEY.
    2019 Shepherd, A., O'Callaghan, M., & Sutherland, P. (2019). Does eligibility for active surveillance of prostate cancer affect functional outcomes after radical prostatectomy?. In BJU INTERNATIONAL Vol. 123 (pp. 51). Brisbane, AUSTRALIA: WILEY.
    2019 Forgione, M., Sara, S., Vincent, A. D., Borg, M., Moretti, K., & O'Callaghan, M. E. (2019). Satisfaction with care in men with prostate cancer. In Abstracts of the 2nd Prostate Cancer World Congress (PCWC 2015), as published in BJU International Vol. 116 (pp. 22-23). Cairns, AUSTRALIA: Wiley.
    DOI
    2017 Li, M., Osei-Tutu, L., Lee, J., & O'Callaghan, M. (2017). CT scan for prostate cancer staging - Prevalence of incidentalomas and does it affect management?. In BJU INTERNATIONAL Vol. 120 (pp. 25-26). MALAYSIA: WILEY.
    WoS1
    2017 Das, K., Ordones, F. V., Fuller, A., O'Callaghan, M., & Brook, N. R. (2017). COMPARISON OF ONCOLOGICAL AND FUNCTIONAL OUTCOMES FOLLOWING RADICAL PROSTATECTOMY IN CLINICAL T2 AND CLINICAL T3 PROSTATE CANCERS: FINDINGS FROM THE SA-PCOCC DATABASE.. In JOURNAL OF UROLOGY Vol. 197 (pp. E631). Boston, MA: ELSEVIER SCIENCE INC.
    DOI
    2017 Ellsworth, J. L., Smith, L., Rubin, H., Seymour, A., Morales, P., Chlipala, E., & O'Callaghan, M. (2017). Widespread Transduction of the Central Nervous System Following Systemic Delivery of AAVHSC17 in Non-Human Primates. In MOLECULAR THERAPY Vol. 25 (pp. 262). DC, Washington: CELL PRESS.
    WoS1
    2017 Ellsworth, J. L., Rubin, H., Seymour, A., & O'Callaghan, M. (2017). Prevalence of Neutralizing Antibodies Targeting Two Novel Clade F AAV in Human Sera. In MOLECULAR THERAPY Vol. 25 (pp. 89). DC, Washington: CELL PRESS.
    2016 Nag, N., Kedda, M. -A., Gourlay, C., Sampurno, F., O'Callaghan, M., Teuss, S., . . . Evans, S. M. (2016). Towards national reporting on prostate cancer care. In BJU INTERNATIONAL Vol. 118 (pp. 8). Melbourne, AUSTRALIA: WILEY-BLACKWELL.
    2016 Shepherd, A., Beckmann, K., & O'Callaghan, M. (2016). Clinical outcomes for rural patients with prostate cancer in South Australia. In BJU INTERNATIONAL Vol. 117 (pp. 106-107). Gold Coast, AUSTRALIA: WILEY-BLACKWELL.
    2016 Mathur, N., Beckmann, K., Moretti, K., Kopsaftis, T., D'Onise, K., Walsh, S., & O'Callaghan, M. (2016). A review of the incidence, management and prognosis of the ductal subtype of prostate cancer. In BJU INTERNATIONAL Vol. 117 (pp. 97-98). Gold Coast, AUSTRALIA: WILEY-BLACKWELL.
    2016 Beckmann, K., O'Callaghan, M., Vincent, A., Ruseckaite, R., Roder, D., Evans, A. S., & Moretti, K. (2016). Application of International Society of Urological Pathology's (ISUP) new grade categories for prostate cancer: outcomes and upgrading in South Australia (SA). In BJU INTERNATIONAL Vol. 117 (pp. 35-36). Gold Coast, AUSTRALIA: WILEY-BLACKWELL.
    2016 Beckmann, K., Vincent, A., O'Callaghan, M., Sampurno, F., Ruseckaite, R., Evans, S., . . . Moretti, K. (2016). Oncological outcomes in an Australian cohort according to the new International Society of Urological Pathology (ISUP-2014) prostate cancer grading categories. In BJU INTERNATIONAL Vol. 118 (pp. 16-17). Melbourne, AUSTRALIA: WILEY-BLACKWELL.
    2015 Ang, M., Rajic, B., Foreman, D., & O'Callaghan, M. (2015). Men presenting with prostate specific antigen (PSA) levels over 100 ng/mL at the time of diagnosis. In BJU INTERNATIONAL Vol. 116 (pp. 23). Cairns, AUSTRALIA: WILEY-BLACKWELL.
    2015 O'Callaghan, M., Shi, Z., Walsh, S., Kopsaftis, T., & Moretti, K. (2015). Delays in prostate cancer treatment following diagnosis. In BJU INTERNATIONAL Vol. 116 (pp. 21-22). Cairns, AUSTRALIA: WILEY-BLACKWELL.
    2015 Beckmann, K., O'Callaghan, M., Ruseckaite, R., Moretti, K., Evans, S., Millar, J., . . . Roder, D. (2015). The changing profile of prostate cancer in South Australia. In BJU INTERNATIONAL Vol. 116 (pp. 20-21). Cairns, AUSTRALIA: WILEY-BLACKWELL.
    2015 Shepherd, A., & O'Callaghan, M. (2015). Eligibility for active surveillance of prostate cancer and functional outcomes after prostatectomy. In BJU INTERNATIONAL Vol. 115 (pp. 33). Adelaide, AUSTRALIA: WILEY-BLACKWELL.
    2015 Mack, D., Poulard, K., Goddard, M., Snyder, J., Grange, R., Doering, J., . . . Buj-Bello, A. (2015). Peripheral vein injection of AAV8-MTM1 leads to long-term survival and correction of severe muscle pathology in a canine model of X-linked myotubular myopathy: Results from a dose escalation study. In NEUROMUSCULAR DISORDERS Vol. 25 (pp. S274). ENGLAND, Brighton: PERGAMON-ELSEVIER SCIENCE LTD.
    DOI
    2015 Mack, D. L., Poulard, K., Goddard, M., Snyder, J. M., Grange, R. W., Doering, J., . . . Childers, M. K. (2015). Minimally Effective Dose of Systemic AAV8-MTM1 Needed To Prolong Survival and Correct Severe Muscle Pathology in a Canine Model of X-Linked Myotubular Myopathy. In MOLECULAR THERAPY Vol. 23 (pp. S201). LA, New Orleans: NATURE PUBLISHING GROUP.
    DOI
    2015 Lawlor, M., Mack, D., Poulard, K., Goddard, M., Snyder, J., Grange, R., . . . Childers, M. (2015). AAV8-MTM1 results in long-term survival and correction of severe muscle pathology in a canine model of X-linked myotubular myopathy. In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Vol. 74 (pp. 617). CO, Denver: LIPPINCOTT WILLIAMS & WILKINS.
    2014 Mack, D. L., Goddard, M., Snyder, J. M., Doering, J., Lawlor, M. W., Moullier, P., . . . Childers, M. (2014). Canine X-linked myotubular myopathy: A dose-finding study of systemic AAV8-MTM1 effects on muscle strength, gait, respiration, neuromuscular function and survival. In NEUROMUSCULAR DISORDERS Vol. 24 (pp. 807). GERMANY, Berlin: PERGAMON-ELSEVIER SCIENCE LTD.
    DOI
    2014 Mack, D. L., Goddard, M., Snyder, J. M., Grange, R. W., Doering, J. A., Lawlor, M. W., . . . Childers, M. K. (2014). Dose-Response Effects Following Systemic Infusion of AAV8-MTM1 on Muscle Strength, Walking Speed, Respiration, Neuromuscular Function and Survival in a Canine Model of X-Linked Myotubular Myopathy. In MOLECULAR THERAPY Vol. 22 (pp. S198-S199). DC, Washington: CELL PRESS.
    2014 Roberts, R., Miller, M., O'Callaghan, M., & Koczwara, B. (2014). BONE HEALTH MANAGEMENT OF BREAST AND PROSTATE CANCER SURVIVORS RECEIVING HORMONAL THERAPY. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 10 (pp. 165). WILEY-BLACKWELL.
    2014 O'Callaghan, M., Pinnock, C., Hall, K., Walsh, S., Kopsaftis, T., & Moretti, K. (2014). Prostate cancer recurrence and delays in care following an elevated PSA. In BJU INTERNATIONAL Vol. 113 (pp. 38). Brisbane, AUSTRALIA: WILEY-BLACKWELL.
    2010 O'Callaghan, M. E., MacLennan, A. H., Goldwater, P. N., McMichael, G., & et al. (2010). Australian Collaborative Study of genomic and environmental factors associated with CP. In Conference Proceedings. Sydney, Australia.
    2008 McPherson, L., Lennox, N., Bain, C., Carrington, S., Williams, G., & O'Callaghan, M. (2008). Recruitment and retention difficulties in a RCT involving adolescents with intellectual disability. In JOURNAL OF INTELLECTUAL DISABILITY RESEARCH Vol. 52 (pp. 750). WILEY-BLACKWELL.
    2003 O'Callaghan, F., O'Callaghan, M., Najman, J., Williams, G. M., & Bor, W. (2003). Maternal alcohol consumption during pregnancy and physical outcomes up to 5 years of age: A longitudinal study. In AUSTRALIAN JOURNAL OF PSYCHOLOGY Vol. 55 (pp. 200-201). AUSTRALIAN PSYCHOLOGICAL SOC.
    - Lennox, N., Bain, C., Carrington, S., O'Callaghan, M., McPherson, L., & Ware, R. (n.d.). Improving health advocacy and health outcomes in adolescents with intellectual disabilities. In JOURNAL OF INTELLECTUAL DISABILITY RESEARCH Vol. 60 (pp. 695). WILEY-BLACKWELL.

  • Conference Items
    Year Citation
    2022 O'Callaghan, M., Roberts, M., Moretti, K., Frydenberg, M., Gilbourd, D., Mark, S., . . . Papa, N. (2022). Variation in patient reported outcomes following radical prostatectomy: A bi-national registry based study. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF UROLOGY. WILEY.
    2017 Lin, D., Plagakis, S., O'Callaghan, M., Neumann, P., Fuller, A., Wells, R., . . . Foreman, D. (2017). Does age, BMI or prostate volume affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?. Poster session presented at the meeting of BJU INTERNATIONAL. Canberra, AUSTRALIA: WILEY-BLACKWELL.
    DOI
    2017 Aref, A. T., Vincent, A., O'Callaghan, M., Hoy, A., Butler, L., & Wittert, G. (2017). The inverse relationship between prostate specific antigen (PSA) and obesity in healthy men; support for a hormonal, rather than haemodilution mechanism. Poster session presented at the meeting of Abstracts of the 2017 ANZUP Annual Scientific Meeting, as published in Asia-Pacific Journal Of Clinical Oncology. Melbourne, VIC: Wiley.
    DOI
    2017 Campbell, J., Raymond, E., O'Callaghan, M., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). OPTIMUM TOOLS FOR PREDICTING CLINICAL OUTCOMES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY: A SYSTEMATIC REVIEW OF PROGNOSTIC ACCURACY AND VALIDITY. Poster session presented at the meeting of JOURNAL OF UROLOGY. MA, Boston: ELSEVIER SCIENCE INC.
    DOI WoS1
    2016 Neumann, P., O'Callaghan, M., Foreman, D., Plagakis, S., Sutherland, P., Fuller, A., & Wells, R. (2016). Bladder neck displacement and continence outcomes within 12 months of robot assisted radical prostatectomy (RARP). Poster session presented at the meeting of BJU INTERNATIONAL. Melbourne, AUSTRALIA: WILEY-BLACKWELL.
    2016 Plagakis, S., O'Callaghan, M., Neumann, P., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (2016). Age does not affect continence outcome following robot assisted laparoscopic radical prostatectomy (RALP). Poster session presented at the meeting of BJU INTERNATIONAL. Melbourne, AUSTRALIA: WILEY-BLACKWELL.
    2015 Vatandoust, S., Kichenadasse, G., O'Callaghan, M. E., Kopsaftis, T., Walsh, S., Borg, M., . . . Moretti, K. L. (2015). Antiandrogen withdrawal (AAWD) in patients (pts) with prostate cancer (PCa): Retrospective analysis of data from the South Australian Prostate Cancer Clinical Outcome Collaborative (SA-PCCOC).. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
    DOI WoS1
    2015 Ruseckaite, R., Beckman, K., O'Callaghan, M., Roder, D., Moretti, K., Millar, J., . . . Evans, S. (2015). A retrospective analysis of South Australian and Victorian clinical registries for prostate cancer. Poster session presented at the meeting of BJU INTERNATIONAL. Cairns, AUSTRALIA: WILEY-BLACKWELL.
    2014 Foreman, D., Plagakis, S., Edwards, S., & O'Callaghan, M. (2014). How does T and N stage affect survival following cystectomy for transitional cell cancer of the bladder in a South Australian population?. Poster session presented at the meeting of Abstracts of the 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, as published in BJU International. Brisbane, Australia: Wiley-Blackwell.
    DOI

Funding and Awards

Grants
Year Grant CI's / PI's Amount
2021 Infrastructure grant – SA-PCCOC – The Hospital Research Foundation. K Moretti, M O’Callaghan  
2020 SA Prostate Cancer Outcomes Registry – Movember Foundation ( K Moretti, M O’Callaghan  
2019 Beat Cancer Infrastructure Grant - Prostate Cancer in South Australia – Improving Quality Treatment and Accelerating Research K Moretti, M O’Callaghan  
2019 SA Prostate Cancer Outcomes Registry – Movember Foundation K Moretti; AIs: M O’Callaghan, S Walsh, T Kopsaftis  
2019 Predicting Urinary Incontinence and Erectile Dysfunction after Prostate Cancer Surgery. - Movember Clinical Quality Improvement Research Program K Moretti, M O’Callaghan, A Vincent, K Beckmann, D Smith, S Mark, M Frydenberg, S Evans, J Clarke, S Walsh, T Kopsaftis, M Evans, D Merry.  
2019 Evaluating the benefits, harms and cost-effectiveness of variation in compliance with best practice guidelines for the treatment of localised prostate cancer – Movember Clinical Quality Improvement Research Program D Smith, M Patel, S Sengupta, I Vela, A Kneebone, H Woo, S Evans, M O’Callaghan, D Cancian, K Canfell, K Chiam, M Caruana.  
2018 SA Prostate Cancer Outcomes Registry – Movember Foundation K Moretti; AIs: M O’Callaghan, S Walsh, T Kopsaftis  
2018 Beat Cancer Infrastructure Grant - Prostate Cancer in South Australia – Improving Quality Treatment and Accelerating Research K Moretti, M O’Callaghan  
2018 2018/19 Below the Belt Research Fund - Why do men leave active surveillance? A mixed methods investigation examining factors contributing to adherence on active surveillance. Camile Short; AIs: M McIntosh, M Opozda, D Galvao, A Vincent, M O’Callaghan.  
2018 2018 Clinical project grant – Royal Adelaide Hospital - Influence of obesity and lipid abnormalities on prostate cancer aggressiveness among men treated for prostate cancer at the Royal Adelaide Hospital P Sutherland; AIs: A Aref, L Butler, G Wittert, A Vincent, M O’Callaghan  
2017 SA Prostate Cancer Outcomes Registry – Movember Foundation K Moretti; AIs: M O’Callaghan, S Walsh, T Kopsaftis  

2017

 SA Prostate Cancer Outcomes Registry – The Hospital Research Foundation K Moretti; AIs: M O’Callaghan, S Walsh, T Kopsaftis  
 
Awards
Year Award
2018 Shortlisted for the 2018 Flinders Centre for Innovation in Cancer HDR Supervisor Award
 

Teaching and Mentorship

Urology Registrars and RMO's
2019 Dr Gary Wang, Registrar, FMC – Prostate Cancer Outcomes in men diagnosed with Gleason 10 pathology
2018 Dr Gary Wang, Registrar, FMC – Prostate Cancer Outcomes in men aged 90 and over at diagnosis
2017 Dr Diwei Lin, Registrar, RGH –Urethral length and continence post RALP
2017 Dr Tom Cundy, Registrar, RGH – Paediatric Urologic Cancers in Australia
PhD Students
2016-2019 Dr Adel Aref, PhD Candidate, University of Adelaide, Discipline of Medicine, Freemasons Foundation for Men’s Health Centre. Supervisors: Lisa Butler, Andrew Vincent, Gary Wittert, M O’Callaghan, Andrew Hoy.
This thesis received a Dean’s letter of commendation.

 

Master Students
2020 Dr Jake Tempo, MSurg Candidate, Flinders University
Supervisors: M O’Callaghan, D Watson
2020 Dr Georgina Williams, MSurg Candidate, Flinders University
Supervisors: M O’Callaghan, D Watson
2019 - 2021 Dr Matthew Borg, MSc candidate, University of Adelaide
Supervisors: A Vincent, M O’Callaghan
2019 Dr Athul John, MPhil (Surg) Candidate, University of Adelaide.
Supervisors: M O’Callaghan, L Selth, R Catterwell
2018 Dr Rowan David, Masters of Surgery Candidate, Flinders University, Discipline of Surgery. Supervisors: M O’Callaghan, D Watson, J Lee.
2018 - 2019 Dr Minh Tran, Masters of Surgical Sciences, The University of Edinburgh, Edinburgh Medical School. Research Supervisor: M O’Callaghan

 

Honours Students
2018 Ms Mrunal Hiwase– Prediction of Metastatic Prostate Cancer (University of Adelaide) – Supervisors: M O’Callaghan, A Vincent. First Class honours
2018 Stamati Morias – Mentor – Honors Radiation Therapy – University of South Australia
Supervisors: Michala Short, Elizabth Buckley, Kerri Beckmann

 

Undergraduate Students
2020 Ms Meg Prosser, Radiation Therapy Student, University of South Australia, Summer Vacation Research Scholarship, Freemason’s Foundation for Men’s Health – Bowel Health after Radiation Treatment of Prostate Cancer.
2018 Mr Adam Hamilton, 3rd Year Bachelor of Mathematical Studies, University of Adelaide, Summer Vacation Research Scholarship, Freemason’s Foundation for Men’s Health – Hidden mathematics in genitourinary anatomy. Co-supervisors Dr Thomas Cundy, Prof Tony Roberts, Dr Mark Sparnon

Classes

2017 - present Southern Adelaide Local Health Network Urology Journal Club. Held bi-monthly for urology fellows, registrars, resident medical officers, students and clinicians. This journal club reviews, critiques and discusses the latest publications in the urology literature. Paper summaries and critiques are published at: www.wikijournalclub.org 

 

 

  • Current Higher Degree by Research Supervision (University of Adelaide)
    Date Role Research Topic Program Degree Type Student Load Student Name
    2023 Principal Supervisor Defining and describing different clinical phenotypes of local and metastatic prostate cancer using Prostate Specific Membrane Antigen PET Doctor of Philosophy Doctorate Part Time Dr Mrunal Devendra Hiwase
    2021 Principal Supervisor Pathological parameters of positive surgical margins Doctor of Philosophy Doctorate Part Time Dr Athul Francis John

  • Past Higher Degree by Research Supervision (University of Adelaide)
    Date Role Research Topic Program Degree Type Student Load Student Name
    2016 - 2019 Co-Supervisor Defining the Role of Lipids and Metabolic Factors as Risk Factors for Prostate Cancer Incidence and Aggressiveness Doctor of Philosophy Doctorate Full Time Dr Adel Aref

  • Committee Memberships
    Date Role Committee Institution Country
    2020 - ongoing Member Steering Committee of the South Australian Clinical Cancer Registry South Australian Clinical Cancer Australia
    2019 - ongoing Member Radiation Oncology Quality Indicator Working Group Prostate Cancer Outcomes Registry Australia and New Zealand Australia
    2018 - ongoing Member Prostate Cancer Symposium South Australian Prostate Cancer Clinical Outcomes Collaborative Australia
    2017 - ongoing Member Prostate Cancer Symposium South Australian Prostate Cancer Clinical Outcomes Collaborative Australia
    2017 - 2017 Chair Clinical Registries Oral Presentation Session, Flinders Health Research Week, Flinders Medical Centre Australia
    2017 - ongoing Member Surgical Quality Indicator Working Group Prostate Cancer Outcomes Registry Australia and New Zealand Australia

  • Memberships
    Date Role Membership Country
    2014 - ongoing Member Urological Society of Australia and New Zealand, Australia
    2014 - ongoing Member Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group Australia
    2014 - ongoing Member Freemasons Foundation Centre for Men’s Health Australia
Connect With Me
External Profiles